| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $785.0M | -4.7% |
| Cost of Revenue | $252.3M | -12.1% |
| Gross Profit | $532.7M | -0.8% |
| R&D Expense | $39.1M | +148.9% |
| SG&A Expense | $211.2M | -2.8% |
| Operating Income | $56.7M | +270.3% |
| Pre-tax Income | $17.0M | +125.8% |
| Income Tax | $16.7M | +103.7% |
| Net Income | $307K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.8M | -34.1% |
| Accounts Receivable | $136.4M | -15.6% |
| Current Assets | $178.9M | -15.1% |
| Total Assets | $688.6M | -3.3% |
| Current Liabilities | $179.6M | -8.5% |
| Long-term Debt | $253.5M | -10.8% |
| Stockholders' Equity | $218.1M | +10.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $63.5M | -29.2% |
| Investing Cash Flow | -$32.5M | +70.5% |
| Financing Cash Flow | -$38.5M | -300.2% |
| +100.4% |
| EPS (Basic) | $0.01 | +100.5% |
| EPS (Diluted) | $0.01 | +100.5% |